Want to see MNPR full AI Analyst Report?
MNPR Analyst Ratings
Strong Buy
9 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MNPR Stock 12 Month Forecast
Average Price Target
$115.56
▲(5.17% Upside)
| Highest Price Target$130.00 | Average Price Target$115.56 | Lowest Price Target$101.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Barclays
$125
Buy
13.77%
Upside
Reiterated
07/23/26
H.C. Wainwright
$105→$125
Buy
13.77%
Upside
Reiterated
07/22/26
Morgan Stanley
$115
Buy
4.67%
Upside
Reiterated
07/22/26
BTIG
$117
Buy
6.49%
Upside
Reiterated
07/22/26
Lake Street
$103
Buy
-6.25%
Downside
Reiterated
06/30/26
JonesTrading
$130
Buy
18.32%
Upside
Reiterated
06/29/26
Piper Sandler
$101
Buy
-8.07%
Downside
Reiterated
06/29/26
Cantor Fitzgerald
$109
Buy
-0.79%
Downside
Reiterated
05/14/26
Raymond James
$142→$123
Buy
11.95%
Upside
Reiterated
11/14/25
Chardan Capital
$60→$85
Buy
-22.64%
Downside
Reiterated
09/25/25
Brookline Capital Markets
$52→$93
Buy
-15.35%
Downside
Reiterated
09/25/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
$125
Buy
13.77%
Upside
Reiterated
07/23/26
H.C. Wainwright
$105→$125
Buy
13.77%
Upside
Reiterated
07/22/26
Morgan Stanley
$115
Buy
4.67%
Upside
Reiterated
07/22/26
BTIG
$117
Buy
6.49%
Upside
Reiterated
07/22/26
Lake Street
$103
Buy
-6.25%
Downside
Reiterated
06/30/26
JonesTrading
$130
Buy
18.32%
Upside
Reiterated
06/29/26
Piper Sandler
$101
Buy
-8.07%
Downside
Reiterated
06/29/26
Cantor Fitzgerald
$109
Buy
-0.79%
Downside
Reiterated
05/14/26
Raymond James
$142→$123
Buy
11.95%
Upside
Reiterated
11/14/25
Chardan Capital
$60→$85
Buy
-22.64%
Downside
Reiterated
09/25/25
Brookline Capital Markets
$52→$93
Buy
-15.35%
Downside
Reiterated
09/25/25
Best Analysts Covering Monopar Therapeutics Inc
3 Months
Success Rate
7/9 ratings generated profit
Average Return
+52.20%
Copying Andres Y. Maldonado's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +52.20% per trade.
1 Year
Success Rate
7/7 ratings generated profit
Average Return
+107.50%
Copying Kristen Kluska's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +107.50% per trade.
2 Years
Success Rate
7/7 ratings generated profit
Average Return
+121.86%
Copying Biren Amin's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +121.86% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MNPR Analyst Recommendation Trends
Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
11
17
17
12
4
Buy
0
0
5
10
10
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
18
23
23
14
Each month's total comprises the sum of three months' worth of ratings.
MNPR Financial Forecast
MNPR Stock Forecast FAQ
What is MNPR’s average 12-month price target, according to analysts?
Based on analyst ratings, Monopar Therapeutics Inc’s 12-month average price target is 115.56.
What is MNPR’s upside potential, based on the analysts’ average price target?
Monopar Therapeutics Inc has 5.17% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MNPR a Buy, Sell or Hold?
Monopar Therapeutics Inc has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
What is Monopar Therapeutics Inc’s price target?
The average price target for Monopar Therapeutics Inc is 115.56. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $130.00 ,the lowest forecast is $101.00. The average price target represents 5.17% Increase from the current price of $109.87.
The highest analyst price target is $130.00 ,the lowest forecast is $101.00. The average price target represents 5.17% Increase from the current price of $109.87.
What do analysts say about Monopar Therapeutics Inc?
Monopar Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of MNPR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.